These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 32167927)
1. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples. Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Kitano M; Rahbari R; Patterson EE; Steinberg SM; Prasad NB; Wang Y; Zeiger MA; Kebebew E Thyroid; 2012 Mar; 22(3):285-91. PubMed ID: 22304369 [TBL] [Abstract][Full Text] [Related]
3. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy. Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557 [TBL] [Abstract][Full Text] [Related]
4. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases. Shen R; Liyanarachchi S; Li W; Wakely PE; Saji M; Huang J; Nagy R; Farrell T; Ringel MD; de la Chapelle A; Kloos RT; He H Thyroid; 2012 Jan; 22(1):9-16. PubMed ID: 22136206 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic and prognostic role of miR-146b-5p in differentiated thyroid carcinomas. Ferraz C; Cunha GB; de Oliveira MMB; Tenório LR; Cury AN; Padovani RDP; Ward LS Front Endocrinol (Lausanne); 2024; 15():1390743. PubMed ID: 39036050 [TBL] [Abstract][Full Text] [Related]
8. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management. Panebianco F; Mazzanti C; Tomei S; Aretini P; Franceschi S; Lessi F; Di Coscio G; Bevilacqua G; Marchetti I BMC Cancer; 2015 Nov; 15():918. PubMed ID: 26581891 [TBL] [Abstract][Full Text] [Related]
9. Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules. Kaliszewski K; Diakowska D; Wojtczak B; Strutyńska-Karpińska M; Domosławski P; Sutkowski K; Głód M; Balcerzak W; Forkasiewicz Z; Łukieńczuk T PLoS One; 2016; 11(1):e0146883. PubMed ID: 26784518 [TBL] [Abstract][Full Text] [Related]
10. Expression of micro-ribonucleic acids in thyroid nodules and serum to discriminate between follicular adenoma and cancer in patients with a fine needle aspiration biopsy classified as suspicious for follicular neoplasm: A preliminary study. Świrta JS; Wątor G; Seweryn M; Kapusta P; Barczyński M; Wołkow P Adv Clin Exp Med; 2023 Sep; 32(9):997-1007. PubMed ID: 36897102 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples. Zhang Y; Zhong Q; Chen X; Fang J; Huang Z Tumour Biol; 2014 Sep; 35(9):9343-53. PubMed ID: 24943685 [TBL] [Abstract][Full Text] [Related]
12. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Kitano M; Rahbari R; Patterson EE; Xiong Y; Prasad NB; Wang Y; Zeiger MA; Kebebew E Ann Surg Oncol; 2011 Nov; 18(12):3443-52. PubMed ID: 21553140 [TBL] [Abstract][Full Text] [Related]
13. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases. Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration. Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Kebebew E; Peng M; Reiff E; McMillan A Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775 [TBL] [Abstract][Full Text] [Related]
16. miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses. Yang F; Zhang H; Leng X; Hao F; Wang L Br J Biomed Sci; 2018 Jan; 75(1):43-45. PubMed ID: 28937915 [No Abstract] [Full Text] [Related]
17. MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis. Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY Clin Endocrinol (Oxf); 2016 Jan; 84(1):127-33. PubMed ID: 25510178 [TBL] [Abstract][Full Text] [Related]
18. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier. Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552 [TBL] [Abstract][Full Text] [Related]
19. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764 [TBL] [Abstract][Full Text] [Related]
20. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]